Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Eickelberg (Munich, Germany). Human translational medicine in ILD: the promise of new drugs. Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD

Member's Comments

No comment yet.

Related content which might interest you: The genetics of asthma and the promise of genomics-guided drug discovery Source: Virtual Congress 2020 – Reducing the burden of asthma Year: 2020 Human translational medicine – phenotyping is key Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 At the interface: the translational science supporting the clinical use of anti-cytokine therapy Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost? Year: 2018 The new Back to Basics section: emerging concepts in basic and translational medicine Source: Eur Respir J 2014; 44: 297-298 Year: 2014 Biologics: current use and future applications for personalised therapy Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021 Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects Source: International Congress 2017 – In the frontline of the fight against tuberculosis Year: 2017 New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012 From Bench to edside: Development of a drug to treat lung disease from a basic research start Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Precision medicine for lung cancer: new targeted treatments  Source: International Congress 2017 – Precision medicine approaches in lung cancer Year: 2017 Bronchiectasis: new therapies and perspectives Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment Year: 2018 Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future? Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 Development of a novel nano-sized carrier system for aeroseol drug delivery (EGE University translational pulmonology research group) Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease Year: 2007 Filling in the gaps- Translational research to develop new therapies  Source: International Congress 2017 – Bronchiectasis: from guidelines to real life Year: 2017 From systems biology to P4 medicine: applications in respiratory medicine Source: Eur Respir Rev, 27 (147) 170110; 10.1183/16000617.0110-2017 Year: 2018 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007